ScoreWhy is Biogen Pharmachem Industries Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 6.65% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.88
2
Flat results in Sep 25
- PBDIT(Q) Lowest at Rs -0.39 cr.
- PBT LESS OI(Q) Lowest at Rs -0.39 cr.
3
With ROE of 1.7, it has a Very Expensive valuation with a 0.7 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -40.32%, its profits have risen by 208% ; the PEG ratio of the company is 0.1
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Non Banking Financial Company (NBFC))
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Biogen Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Biogen Pharma
-40.21%
-1.23
32.66%
Sensex
-4.3%
0.44
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.64%
EBIT Growth (5y)
11.46%
EBIT to Interest (avg)
0.81
Debt to EBITDA (avg)
2.60
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0.43%
ROE (avg)
2.22%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
21
Price to Book Value
0.52
EV to EBIT
51.08
EV to EBITDA
51.08
EV to Capital Employed
0.52
EV to Sales
37.84
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
0.05%
ROE (Latest)
2.51%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
PAT(9M)
Higher at Rs 1.31 Cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Biogen Pharma
Profit After Tax (PAT) - Nine Monthly
At Rs 1.31 cr has Grown at 189.12%
Year on Year (YoY)MOJO Watch
PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 1.31 Cr
than preceding 12 month period ended Dec 2025 of Rs -0.29 crMOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
PAT (Rs Cr)
